SYMPTOMS AND TREATMENT OF THE MALIGNANT CHOLERAdoi:10.1016/S0140-6736(02)94506-XE.C.JenkinsandS.JosephAltmanandJamesFairbankandSDOSLancet
How is cholera contracted? What precautions could you take to lessen your risk of contracting cholera? What are the signs and symptoms of cholera? What is the main risk factor for cholera infection? What are the causes of cholera? What is the treatment for pneumonia for a person that is im...
A Treatise on the Epidemic Cholera; Containing Its History, Symptoms, Autopsy, Etiology, Causes, and Treatment We have already observed that the epidemic reached the most southerly point of the Peninsula of India in January 1819; and it was at this time it first appeared in the Island of ...
chronic and degenerative disease of the bones and joints that occurs primarily in Tibet Autonomous Region but also in other areas of China, Siberia and the Republic of Korea. Its clinical symptoms include joint pain, morning stiffness, enlarged...
Poor medication adherence is a pervasive issue with considerable health and socioeconomic consequences. Although the underlying reasons are generally understood, traditional intervention strategies rooted in patient-centric education and empowerment have
Cholera toxin Proteinaceous toxin secreted by Vibrio cholerae that binds to glycolipids on the cell surface and is responsible for the symptoms of cholera infection. Single-particle tracking (SPT). A single-molecule technique in which the motion of individual molecules is tracked with high temporal ...
霍乱由霍乱弧菌感染肠道引起,最常见病因是摄入被细菌污染的水和食物。患者典型表现为急性腹泻,严重情况可危及生命。 Cholera is an acute diarrheal illness caused by infection of the intestine with Vibrio cholerae bacteria. People can get sick when they swallow food or water contaminated with cholera bacteria...
The pharmacological properties of R. coptidis are attributed to its main bioactive component, berberine. In various studies, Berberine has demonstrated antimicrobial, anti-inflammatory, antioxidant, antidiabetic, and anticancer activities. Furthermore, its effects on metabolic disorders, cardiovascular health...
of pills. We developed two novel polymers: one with a neutral charge which predominantly releases butyrate in the ileum (NtL-ButM), and one with a negative charge which predominantly releases butyrate in the caecum (Neg-ButM). This micelle system allows us to deliver butyrate to its site ...
The management of inflammatory bowel diseases has been widely investigated, especially ulcerative colitis. Thus, studies with the application of new probiotic products are needed in the prevention/treatment of these clinical conditions. The objective of